Trevi Therapeutics Inc

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$18.51

+0.01 (+0.05%)

As of Aug 9, 10:07 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 17 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +18.5% upside

Low Target $18.04

Average Target $21.93

High Target $33.12

Current Price $18.51

Current
$18.51

Target
$21.93

$18.04 $21.93 avg $33.12

Scenario Analysis

Bear Case

$18.04

-2.5%

Low target

Base Case

$21.93

+18.5%

Avg target

Bull Case

$33.12

+78.9%

High target

Risk/Reward

31.1x

Highly favorable

Price in Context

52-Week High

$20.22

-8.5% from high

52-Week Low

$6.55

+182.6% from low

Target vs 52W High

$21.93

+8.5% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+12.2%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+15.5%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+23.9%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+26.7%
BMY Bristol-Myers Squibb Co	Hold	35	40%	$174.50	+169.6%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-36.1%
ZTS Zoetis Inc	Hold	24	54%	$209.87	+188.8%